NASDAQ: VCEL - Vericel Corporation

Yield per half year: +5.53%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Vericel Corporation

Extended chart Simple chart
Financial Markets by TradingView

About Vericel Corporation

Vericel Corporation, коммерческая биофармацевтическая компания, исследует, разрабатывает, производит и распространяет клеточные препараты для спортивной медицины и рынков лечения тяжелых ожогов в Соединенных Штатах. Компания продает продукты аутологичной клеточной терапии, включающие MACI, аутологичный клеточный каркас для восстановления симптоматических, а также единичных или множественных дефектов хряща на всю толщину колена; и Epicel, устройство для перманентной замены кожи, используемое в гуманитарных целях для лечения взрослых и детей с глубокими кожными или полнослойными ожогами.

more details
Его продукт стадии предварительного утверждения включает NexoBrid, биологический орфанный продукт стадии регистрации для удаления струпа у взрослых с глубокими частичными и / или полными термическими ожогами. Компания ранее была известна как Aastrom Biosciences, Inc. Vericel Corporation была зарегистрирована в 1989 году, ее штаб-квартира находится в Кембридже, Массачусетс.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 1997-02-04
ISIN US92346J1088
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт https://vcel.com
Цена ао 46.51
Change price per day: -3.03% (47.96)
Change price per week: -1.95% (47.43)
Change price per month: -11.13% (52.33)
Change price per 3 month: -18.85% (57.31)
Change price per half year: +5.53% (44.07)
Change price per year: -11.13% (52.33)
Change price per 3 year: +31.04% (35.49)
Change price per 5 year: +209% (15.05)
Change price per year to date: -17.97% (56.69)
All parameters

Underestimation

Title Value Grade
P/S 8.37 1
P/BV 7.32 1
P/E 3490 1
EV/EBITDA -903.4 0
Total: 1.75

Efficiency

Title Value Grade
ROA, % -0.8997 0
ROE, % -1.41 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -48.11 10
Total: 9.8

Growth impulse

Title Value Grade
Yield Revenue, % 67.39 8
Yield Ebitda, % -136.19 0
Yield EPS, % -69.61 0
Total: 1.6
More

Institutions Volume Share, %
Blackrock Inc. 7937063 16.41
Brown Capital Management, LLC 6818933 14.09
Vanguard Group Inc 3374093 6.97
RTW Investments LP 3212794 6.64
State Street Corporation 2664883 5.51
Conestoga Capital Advisors, LLC 2339960 4.84
GW&K Investment Management, LLC 1323306 2.74
Morgan Stanley 1297846 2.68
Macquarie Group Limited 1146193 2.37
Loomis Sayles & Company, LP 1141526 2.36

ETFShare, %Profitability for 1 year, %Dividends, %
Invesco Biotechnology & Genome ETF 2.37902 26.49 0.16298
WisdomTree BioRevolution Fund 1.93517 -29.24 0.78691
Invesco S&P SmallCap Health Care ETF 1.65356 -7.89 0.41696
Invesco S&P SmallCap 600® Pure Growth ETF 0.83989 32.37 1.34638
Syntax Stratified SmallCap ETF 0.77303 13.51 1.639
Invesco S&P SmallCap Momentum ETF 0.59162 42.6 1.30511
Vanguard S&P Small-Cap 600 Growth ETF 0.37 30.31 1.37064
SPDR S&P 600 Small Cap Growth ETF 0.36014 -11.55 1.33495
Direxion Daily S&P Biotech Bull 3x Shares 0.25817 4067.92 0.25924
SPDR S&P SmallCap 600 ESG ETF 0.25663 18.95 1.85316
VictoryShares US Small Mid Cap Value Momentum ETF 0.23021 36.19 1.97666
First Trust Small Cap Growth AlphaDEX Fund 0.22991 42.5 1.22182
Invesco Nasdaq Biotechnology ETF 0.22543 28.58 0.8565
Future Tech ETF 0.22468 426.34 0.8416
Principal Healthcare Innovators ETF 0.22468 618.5 0.8416
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.19345 31.36 1.41955
Vanguard S&P Small-Cap 600 ETF 0.19 -11.97 1.89226
Vanguard Russell 2000 Growth ETF 0.19 -10.8 0.60264
SPDR Portfolio S&P 600 Small Cap ETF 0.17823 -11.2 1.84119
iShares Russell 2000 Growth ETF 0.16678 38.04 0.6026
Franklin U.S. Small Cap Multifactor Index ETF 0.16243 -11.59 1.90721
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.15296 24.75 1.59225
ProShares Ultra Nasdaq Biotechnology 0.14975 51.7 0.85651
Invesco Russell 2000 Dynamic Multifactor ETF 0.13879 -7.22 1.64004
Principal U.S. Small-Cap ETF 0.1374 -8.13 1.20466
Fidelity Small-Mid Multifactor ETF 0.12435 32.31 1.59943
ProShares Ultra SmallCap600 0.12217 49.8 1.83727
iShares Morningstar Small-Cap Growth ETF 0.09689 572.1 0.72598
iShares Morningstar Small-Cap Growth ETF 0.09689 33.63 0.72598
Vanguard Russell 2000 ETF 0.09 -10.48 1.48801
First Trust Small Cap Core AlphaDEX Fund 0.0598 -10.11 1.87983
Schwab U.S. Small-Cap ETF 0.05841 -10.22 1.51433
Vanguard U.S. Momentum Factor ETF 0.05 -9.95 1.05834
First Trust Multi Cap Growth AlphaDEX Fund 0.04967 41.56 1.02425
ProShares UltraPro Russell2000 0.04875 89.82 1.47873
iShares Morningstar Small-Cap ETF 0.04872 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.04872 391.25 1.60498
Fidelity MSCI Health Care Index ETF 0.03154 -4.29 1.46057
Invesco S&P SmallCap 600 Revenue ETF 0.01492 30.92 1.94562
ProShares Hedge Replication ETF 0.01376 5.92 1.47892
Humankind US Stock ETF 0.01232 18.81 1.99919
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.01188 -10.38 1.75869
SPDR S&P 1500 Momentum Tilt ETF 0.00482 38.25 1.12176
SPDR Portfolio S&P 1500 Composite Stock Market ETF 0.00434 0.2045 1.46083
Dimensional U.S. Core Equity 2 ETF 0.00432 30.76 1.47098
Schwab U.S. Broad Market ETF 0.00389 -0.4495 1.43354
iShares Russell 3000 ETF 0.00366 0.0303 1.43482
Dimensional US Core Equity Market ETF 0.00343 30.98 1.40618
Dimensional U.S. Equity ETF 0.00343 31.53 1.3557
SPDR S&P 1500 Value Tilt ETF 0.00076 27.15 2.3833
Vanguard Russell 3000 ETF 0 31.87 1.43817
0.26134.351.34



Head Job title Payment Year of birth
Mr. Dominick C. Colangelo Esq. CEO, President & Director 1.54M 1964 (61 year)
Mr. Michael Halpin Chief Operating Officer 796.91k 1962 (63 years)
Mr. Joseph Anthony Mara Jr. CFO & Treasurer 750.61k 1976 (49 years)
Mr. Eric Burns Vice President of Finance & Investor Relations N/A
Mr. Patrick J. Fowler Senior Vice President of Corporate Development & Strategy N/A
Dr. Jonathan M. Hopper FRCSEd., M.B. Ch.B. Chief Medical Officer 672.16k 1962 (63 years)
Mr. Patrick Helfrich Vice President of Marketing & Commercial Strategy N/A
Mr. Jonathan D. Siegal Principal Accounting Officer, VP & Corporate Controller N/A
Mr. Sean C. Flynn Chief Legal Officer 1974 (51 year)
Mr. Mike Gilligan Senior Vice President of Sales

Address: United States, Cambridge, MA , 64 Sidney Street - open in Google maps, open in Yandex maps
Website: https://vcel.com